[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Hyaluronidase Market Size, Share & Trends Analysis Report By Type (Animal-derived, Synthetic), By Application (Dermatology, Chemotherapy, Ophthalmology, Plastic Surgery), By Region And Segment Forecasts, 2019 - 2026

November 2019 | 130 pages | ID: HE508573B5F6EN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The global hyaluronidase market size is expected to reach USD 1,249.58 million by 2026 growing at a CAGR of 8.55%, according to a new report by Grand View Research, Inc. The significance of minimally invasive cosmetic procedures has increased considerably over the years and various demographic research studies have been conducted to evaluate the adoption pattern of cosmetic treatments across the globe, especially in developed countries.

Hyaluronic acid fillers form the most important component of minimally invasive aesthetic procedures carried out across the globe. Since hyaluronidase is mostly preferred while conducting these procedures, a growing number of minimally invasive aesthetic surgeries are expected to positively impact market growth. Dermal fillers have significant applications in minimally invasive facial aesthetic procedures, which has also led to an increase in the number of reported complications.

Clinicians are required to be entirely aware of the symptoms associated with hyaluronic acid injection complications in order to treat them effectively. It is crucial to establish effective protocols of action suitable for emergencies wherein the desired agents are readily available at the site of surgery or treatment. This aids in controlling the adverse impact of hyaluronic acid filler injections.

Further key findings from the study suggest:
  • Animal-derived products accounted for the largest revenue share in 2018 and are anticipated to maintain this trend throughout the forecast period
  • Synthetic hyaluronidase is set to grow with a CAGR of 9.53% from 2019-2026
  • Dermatology dominated among the other applications with a revenue of USD 295.81 million in 2018 and is expected to reach USD 553.62 million by 2026
  • Chemotherapy is projected to be the fastest-growing application segment
  • North America was the leading regional market in 2018 due to the high penetration of novel cosmetic treatments. In addition, dermatologists in this region are developing new non-surgical cosmetic procedures and hyaluronidase-based injectables which are among the highly recommended injectable dermal fillers
  • Asia Pacific is projected to witness the fastest growth owing to the numerous untapped growth opportunities in hyaluronidase-based treatments
  • A robust network of local manufacturers has significantly contributed to the revenue generated from this region
  • Some of the key hyaluronidase market participants are Amphastar Pharmaceuticals, Inc., Halozyme Therapeutics, PrimaPharm, Inc., and Bausch & Lomb Incorporated among others
CHAPTER 1 EXECUTIVE SUMMARY

1.1 Market Snapshot

CHAPTER 2 RESEARCH METHODOLOGY

2.1 Information Procurement
2.2 Information or Data Analysis
2.3 Market Formulation & Validation

CHAPTER 3 HYALURONIDASE MARKET VARIABLES, TRENDS & SCOPE

3.1 Market Segmentation & Scope
  3.1.1 Market driver analysis
    3.1.1.1 Rising demand for minimally invasive aesthetic treatments
    3.1.1.2 Increasing penetration of hyaluronidase in correction procedures
  3.1.2 Market restraint analysis
    3.1.2.1 Adverse effects associated with hyaluronidases
3.2 Penetration & Growth Prospect Mapping for Products, 2018
3.3 Regulatory and Reimbursement Framework
  3.3.1 Regulatory framework
  3.3.2 Reimbursement fcenario
    3.3.2.1 Herceptin Hylecta
      3.3.2.1.1 Breast Cancer
    3.3.2.1 HYQVIA
3.4 Hyaluronidase Market Analysis Tools
  3.4.1 Industry analysis - Porter’s
    3.4.1.1 Supplier power: High
    3.4.1.2 Buyer power: Moderate
    3.4.1.3 Substitution threat: Moderate
    3.4.1.4 Threat of new entrant: Low
    3.4.1.5 Competitive rivalry: Moderate
  3.4.2 PESTEL Analysis
    3.4.2.1 Political & legal landscape
    3.4.2.2 Environmental landscape
    3.4.2.3 Social landscape
    3.4.2.4 Technology landscape
  3.4.3 Major deals & strategic alliances analysis
    3.4.3.1 Joint ventures
    3.4.3.2 Mergers & acquisitions
    3.4.3.3 Licensing & partnership
    3.4.3.4 Technological collaborations
    3.4.3.5 Strategic divestments
  3.4.4 Market entry strategies
  3.4.5 Consumer behavior analysis & market influencers

CHAPTER 4 HYALURONIDASE MARKET CATEGORIZATION: TYPE ESTIMATES & TREND ANALYSIS

4.1 Hyaluronidase Market: Type Movement Analysis
4.2 Animal-derived Hyaluronidase
  4.2.1 Animal-derived hyaluronidase market, 2014 - 2026 (USD Million)
4.3 Synthetic Hyaluronidase
  4.3.1 Synthetic Hyaluronidase market, 2014 - 2026 (USD Million)

CHAPTER 5 HYALURONIDASE MARKET CATEGORIZATION: APPLICATION ESTIMATES & TREND ANALYSIS

5.1 Excipient for subcutaneous injection of antibody therapeutics
5.2 In vitro fertilization (human)
5.3 In vitro fertilization (domestic animals)
5.4 Hyaluronidase Market: Application Movement Analysis
5.5 Dermatology
  5.5.1 Hyaluronidase market for dermatology, 2014 - 2026 (USD Million)
5.6 Chemotherapy
  5.6.1 Hyaluronidase market for chemotherapy, 2014 - 2026 (USD Million)
5.7 Ophthalmology
  5.7.1 Hyaluronidase market for ophthalmology, 2014 - 2026 (USD Million)
5.8 Plastic Surgery
  5.8.1 Hyaluronidase market for plastic surgery, 2014 - 2026 (USD Million)
5.9 Others
  5.9.1 Hyaluronidase market for others, 2014 - 2026 (USD Million)

CHAPTER 6 HYALURONIDASE MARKET CATEGORIZATION: REGIONAL ESTIMATES & TREND ANALYSIS BY TYPE AND APPLICATION

6.1 Hyaluronidase market: Regional movement analysis
6.2 List of Players at Regional Level
  6.2.1 North America
  6.2.2 Europe
  6.2.3 Asia Pacific
  6.2.4 Latin America
  6.2.5 Middle East & Africa
6.3 SWOT Analysis
  6.3.1 Developed Regions (North America & Europe)
  6.3.2 Developing Regions (Asia Pacific, Latin America, & Middle East and Africa)
6.4 North America
  6.4.1 North America hyaluronidase market, 2014 - 2026 (USD Million)
  6.4.2 U.S.
    6.4.2.1 U.S. hyaluronidase market, 2014 - 2026 (USD Million)
  6.4.3 Canada
    6.4.3.1 Canada hyaluronidase market, 2014 - 2026 (USD Million)
6.5 Europe
  6.5.1 Europe hyaluronidase market, 2014 - 2026 (USD Million)
  6.5.2 Germany
    6.5.2.1 Germany hyaluronidase market, 2014 - 2026 (USD Million)
  6.5.3 France
    6.5.3.1 France hyaluronidase market, 2014 - 2026 (USD Million)
  6.5.4 UK
    6.5.4.1 UK hyaluronidase market, 2014 - 2026 (USD Million)
  6.5.5 Italy
    6.5.5.1 Italy hyaluronidase market, 2014 - 2026 (USD Million)
  6.5.6 Spain
    6.5.6.1 Spain hyaluronidase market, 2014 - 2026 (USD Million)
6.6 Asia Pacific
  6.6.1 Asia Pacific hyaluronidase market, 2014 - 2026 (USD Million)
  6.6.2 China
    6.6.2.1 China hyaluronidase market, 2014 - 2026 (USD Million)
  6.6.3 Japan
    6.6.3.1 Japan hyaluronidase market, 2014 - 2026 (USD Million)
  6.6.4 India
    6.6.4.1 India hyaluronidase market, 2014 - 2026 (USD Million)
  6.6.5 South Korea
    6.6.5.1 South Korea hyaluronidase market, 2014 - 2026 (USD Million)
6.7 Latin America
  6.7.1 Latin America hyaluronidase market, 2014 - 2026 (USD Million)
  6.7.2 Brazil
    6.7.2.1 Brazil hyaluronidase market, 2014 - 2026 (USD Million)
  6.7.3 Mexico
    6.7.3.1 Mexico hyaluronidase market, 2014 - 2026 (USD Million)
  6.7.4 Argentina
    6.7.4.1 Argentina hyaluronidase market, 2014 - 2026 (USD Million)
6.8 Middle East and Africa (MEA)
  6.8.1 MEA hyaluronidase market, 2014 - 2026 (USD Million)
  6.8.2 South Africa
    6.8.2.1 South Africa hyaluronidase market, 2014 - 2026 (USD Million)
  6.8.3 UAE
    6.8.3.1 UAE hyaluronidase market, 2014 - 2026 (USD Million)

CHAPTER 7 COMPETITIVE ANALYSIS

7.1 Vendor Landscape
7.2 Company Profiles
  7.2.1 Amphastar Pharmaceuticals, Inc.
    7.2.1.1 Company overview
    7.2.1.2 Financial performance
    7.2.1.3 Product benchmarking
  7.2.2 PrimaPharma, Inc.
    7.2.2.1 Company overview
    7.2.2.2 Product benchmarking
  7.2.3 Halozyme, Inc.
    7.2.3.1 Company overview
    7.2.3.2 Financial performance
    7.2.3.3 Product benchmarking
  7.2.4 Bausch & Lomb Incorporated
    7.2.4.1 Company overview
    7.2.4.2 Financial performance
    7.2.4.3 Product benchmarking
  7.2.5 The Cooper Companies Inc.
    7.2.5.1 Company overview
    7.2.5.2 Financial performance
    7.2.5.3 Product benchmarking
  7.2.6 Sun Pharmaceutical Industries Ltd.
    7.2.6.1 Company overview
    7.2.6.2 Financial performance
    7.2.6.3 Product benchmarking
  7.2.7 STEMCELL Technologies, Inc.
    7.2.7.1 Company overview
    7.2.7.2 Financial performance
    7.2.7.3 Product benchmarking
  7.2.8 Shreya Life Sciences Pvt. Ltd
    7.2.8.1 Company overview
    7.2.8.2 Product benchmarking
LIST OF TABLES

TABLE 1 Recent trends in body shaping procedures in the U.S.
TABLE 2 Assigned codes for hyaluronidase in breast cancer
TABLE 3 FDA approved hyaluronidase products
TABLE 4 North America hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 5 North America hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 6 U.S. hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 7 U.S. hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 8 Canada hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 9 Canada hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 10 Europe hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 11 Europe hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 12 Germany hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 13 Germany hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 14 France hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 15 France hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 16 UK hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 17 UK hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 18 Italy hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 19 Italy hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 20 Spain hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 21 Spain hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 22 Asia Pacific hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 23 Asia Pacific hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 24 China hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 25 China hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 26 Japan hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 27 Japan hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 28 India hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 29 India hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 30 South Korea hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 31 South Korea hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 32 Latin America hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 33 Latin America hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 34 Brazil hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 35 Brazil hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 36 Mexico hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 37 Mexico hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 38 Argentina hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 39 Argentina hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 40 MEA hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 41 MEA hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 42 South Africa hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 43 South Africa hyaluronidase market, by application, 2014 - 2026 (USD Million)
TABLE 44 UAE hyaluronidase market, by type, 2014 - 2026 (USD Million)
TABLE 45 UAE hyaluronidase market, by application, 2014 - 2026 (USD Million)
LIST OF FIGURES

FIG. 1 Market summary
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain-based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Motivations for seeking minimally invasive cosmetic procedures: Academic outpatient setting
FIG. 12 Top five cosmetic surgical procedures in the U.S.: 2018
FIG. 13 Market restraint relevance analysis (Current & future impact)
FIG. 14 Penetration & growth prospect mapping for products, 2018
FIG. 15 Factors impacting market entry strategies
FIG. 16 Key market entry methods
FIG. 17 Hyaluronidase market: Type outlook key takeaways
FIG. 18 Hyaluronidase market: Type movement analysis
FIG. 19 Animal-derived hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 20 Synthetic hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 21 Hyaluronidase market: Application outlook key takeaways
FIG. 22 Hyaluronidase market: Application movement analysis
FIG. 23 Hyaluronidase market for dermatology, 2014 - 2026 (USD Million)
FIG. 24 Hyaluronidase market for chemotherapy, 2014 - 2026 (USD Million)
FIG. 25 Hyaluronidase market for ophthalmology, 2014 - 2026 (USD Million)
FIG. 26 Hyaluronidase market for plastic surgery, 2014 - 2026 (USD Million)
FIG. 27 Hyaluronidase market for others, 2014 - 2026 (USD Million)
FIG. 28 Hyaluronidase market: Regional outlook key takeaways
FIG. 29 Hyaluronidase market: Regional movement analysis
FIG. 30 List of players in North America
FIG. 31 List of players in Europe
FIG. 32 List of players in Asia Pacific
FIG. 33 List of players in Latin America
FIG. 34 List of players in Middle East & Africa
FIG. 35 SWOT Analysis: North America & Europe
FIG. 36 SWOT Analysis: Asia Pacific, Latin America, & Middle East and Africa
FIG. 37 North America hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 38 U.S. hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 39 Canada hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 40 Europe hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 41 Germany hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 42 France hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 43 UK hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 44 Italy hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 45 Spain hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 46 Asia Pacific hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 47 China hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 48 Japan hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 49 India hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 50 South Korea hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 51 Latin America hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 52 Brazil hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 53 Mexico hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 54 Argentina hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 55 MEA hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 56 South Africa hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 57 UAE hyaluronidase market, 2014 - 2026 (USD Million)
FIG. 58 Company market position analysis


More Publications